Project #86: Elucidation of the Regulatory Mechanisms of Naïve T Cells by Gut Microbial Metabolites for Therapeutic Strategies in T1D
Forecasted
This grant supports early-career researchers studying how gut microbial metabolites regulate naïve T cells to develop new therapies for type 1 diabetes.
Funder: Diabetes Research Connection
Due Dates (Anticipated): July 2027 (Full application submission deadline, projected)
Funding Amounts: Up to $75,000 per project for one year; graduate students eligible for up to $50,000, postdocs and junior faculty up to $75,000.
Summary: Supports early-career scientists investigating how gut-derived postbiotics regulate immune cell activation to prevent type 1 diabetes.
Key Information: Only early-career U.S.-based researchers focused on type 1 diabetes are eligible; significant NIH-funded PIs are ineligible.
Description
This opportunity supports innovative, early-stage research into the role of gut microbial metabolites—specifically the postbiotic isoLCA—in regulating naïve T cell function and immune activation related to type 1 diabetes (T1D). The grant aims to advance understanding of how gut microbiome-derived compounds can suppress pro-inflammatory immune responses, potentially informing new therapeutic approaches to prevent T1D onset. The program is part of the Diabetes Research Connection’s mission to fund bold research by early-career investigators in the U.S., leveraging a donor-driven, peer-reviewed funding model.
